SCHEMBL6232

SCHEMBL6232

CC(C)(C)c1ccc(N2CCC3(CCC(CCO)CC3)C2=O)cc1

nearest known ligand 0.49

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
EBP Q15125 1/20 0.49
LIPE Q05469 16/20 0.43
TRPV1 Q8NER1 1/20 0.43
NPC1L1 Q9UHC9 1/20 0.42
HRH3 Q9Y5N1 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12702535 0.82 LIPE (0.46) EBPLIPETRPV1
SCHEMBL12702532 0.82 LIPE (0.46) EBPLIPETRPV1
SCHEMBL10061 0.82 LIPE (0.46) EBPLIPETRPV1
SCHEMBL10062 0.82 LIPE (0.46) EBPLIPETRPV1
SCHEMBL1589334 0.82 LIPE (0.46) EBPLIPETRPV1
SCHEMBL12702580 0.80 EBP (0.44) EBPLIPETRPV1
SCHEMBL1589896 0.80 EBP (0.44) EBPLIPETRPV1
SCHEMBL1589897 0.80 EBP (0.44) EBPLIPETRPV1
SCHEMBL5644 0.80 EBP (0.46) EBPLIPETRPV1HRH3
SCHEMBL9978 0.79 TRPV1 (0.46) EBPLIPETRPV1HRH3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2488493-A1 SPIRO-CONDENSED CYCLOHEXANE DERIVATIVES AS HSL INHIBITORS USEFUL FOR THE TREATMENT OF DIABETES F. Hoffmann-La Roche AG (CH) 2012-08-22 EP disclosed
WO-2011045292-A1 SPIRO-CONDENSED CYCLOHEXANE DERIVATIVES AS HSL INHIBITORS USEFUL FOR THE TREATMENT OF DIABETES F. HOFFMANN-LA ROCHE AG (CH) 2011-04-21 WO disclosed